Trade iBio, Inc. - IBIO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0715 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.001 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.8351 |
| Open | 0.8436 |
| 1-Year Change | -55.1% |
| Day's Range | 0.8038 - 0.9233 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 0.8351 | 0.0811 | 10.76% | 0.7540 | 0.8838 | 0.7192 |
| Apr 23, 2025 | 0.7097 | 0.0133 | 1.91% | 0.6964 | 0.7568 | 0.6670 |
| Apr 22, 2025 | 0.6882 | -0.2627 | -27.63% | 0.9509 | 0.9831 | 0.6276 |
| Apr 21, 2025 | 0.8371 | -0.0242 | -2.81% | 0.8613 | 0.8756 | 0.8295 |
| Apr 17, 2025 | 0.8701 | -0.0969 | -10.02% | 0.9670 | 0.9889 | 0.8570 |
| Apr 16, 2025 | 0.9500 | -0.0770 | -7.50% | 1.0270 | 1.0970 | 0.9425 |
| Apr 15, 2025 | 1.0670 | -0.0500 | -4.48% | 1.1170 | 1.1570 | 1.0670 |
| Apr 14, 2025 | 1.1470 | 0.0000 | 0.00% | 1.1470 | 1.2170 | 1.1370 |
| Apr 11, 2025 | 1.1570 | -0.0200 | -1.70% | 1.1770 | 1.1770 | 1.0670 |
| Apr 10, 2025 | 1.1770 | -0.0100 | -0.84% | 1.1870 | 1.3070 | 1.1370 |
| Apr 9, 2025 | 1.2270 | 0.1000 | 8.87% | 1.1270 | 1.2470 | 1.0270 |
| Apr 8, 2025 | 1.1870 | -0.3100 | -20.71% | 1.4970 | 1.5170 | 1.1770 |
| Apr 7, 2025 | 1.3970 | -1.4500 | -50.93% | 2.8470 | 2.8970 | 1.3470 |
| Apr 4, 2025 | 3.2070 | -0.3100 | -8.81% | 3.5170 | 3.7070 | 3.0170 |
| Apr 3, 2025 | 3.7370 | -0.0900 | -2.35% | 3.8270 | 3.8570 | 3.6270 |
| Apr 2, 2025 | 4.0370 | 0.2700 | 7.17% | 3.7670 | 4.1570 | 3.7570 |
| Apr 1, 2025 | 3.8470 | -0.0200 | -0.52% | 3.8670 | 4.0770 | 3.7570 |
| Mar 31, 2025 | 3.9370 | -0.0200 | -0.51% | 3.9570 | 4.0770 | 3.7770 |
| Mar 28, 2025 | 4.0170 | -0.5600 | -12.24% | 4.5770 | 4.5770 | 3.9870 |
| Mar 27, 2025 | 4.3470 | 0.1400 | 3.33% | 4.2070 | 4.7070 | 4.1770 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
iBio, Inc. Company profile
iBio is a biopharmaceutical company behind the FastPharming System that helps with drug development “from concept to clinic”.
Headquartered in Texas, iBio was founded in 2008 and operates in biopharmaceuticals and bioprocessing segments along with its subsidiary, iBio CDMO LLC.
iBio’s main product is the FastPharming System, which has helped produce monoclonal antibodies, subunit vaccines, cytokines and other recombinant proteins, according to the company’s site.
iBio has also built the Glycaneering Development Services, which provides “greater control over the glycosylation of complex biopharmaceuticals''.
The company operates in the fields of oncology, fibrotic and infectious diseases.
The company’s development and manufacturing services deliver fast, scalable and sustainable solutions, enabling iBio to draw a licence agreement with Planet Biotechnology, and collaboration agreements with CC-Pharming Ltd, Safi BioSolutions and several other companies to develop therapeutic solutions.
The company went public in 2020 on the NYSE American. iBio, Inc. stock trades under the ticker symbol IBIO.
Check out the IBIO price history and today’s share value at Capital.com. Always stay on top of the latest price developments with our live IBIO stock chart.
| Industry: | Construction & Engineering (NEC) |
11740 Katy Fwy
Energy Tower Iii, 11Th Floor
HOUSTON
TEXAS 77079
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com